4//SEC Filing
Call Matthew 4
Accession 0000950170-25-037520
CIK 0001808865other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 8:00 PM ET
Size
7.3 KB
Accession
0000950170-25-037520
Insider Transaction Report
Form 4
Call Matthew
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-07+145,000→ 145,000 totalExercise: $7.05Exp: 2035-03-07→ Common Stock (145,000 underlying) - Award
Common Stock
2025-03-07+24,000→ 161,898 total
Footnotes (2)
- [F1]The reporting person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The shares of common stock underlying the RSUs will vest over 4 years: 25% will vest on March 7, 2026 and the remainder will vest equally, on an annual basis, over the remaining 3 years, subject to the reporting person's continued service to the issuer.
- [F2]This stock option shall vest over four years, with 25% vesting on March 7, 2026 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the issuer.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816207
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 8:00 PM ET
- Size
- 7.3 KB